Navigation Links
Testosterone patch for women Rejected For safety Reasons

The experimental testosterone patch used for treating women with sexual difficulties was rejected by a panel of advisors to the US Food// and Drug Administration recently .

Procter & Gamble, global manufacturer of household products, wants to market the patch to women who have become menopausal after ovarian surgery however due to the rejection by members of the FDA panel the drug is kept on hold until more data is available to assess the drug.

At a recent meeting panel members strongly criticized the company funded clinical trials as "inadequate" to assess issues of long term safety. Panel members also raised serious concerns about the risks of cardiovascular disease and breast cancer associated with a drug that appeared to offer women, on average, little more than one extra episode of sexual activity a month, compared with placebo.

Panel members also say that don't want to expose several million American women to the risk of myocardial infarction and stroke, with such devastating consequences, in order that they can have one more sexual episode a month .

So far no data has been published by Procter & Gamble's after their 24 week randomised controlled trials of the patch . Abstracts presented at conferences have claimed repeatedly that the drug is safe and effective and has side effects similar to those of placebo. Yet data presented at last week's FDA meeting showed that women using testosterone were more likely to experience hair growth, acne, and weight gain.

Procter & Gamble's officials and the company's paid academic consultants have been questioned by the FDA about the clinical meaningfulness of the drug's small benefits, the lack of long term data, and the scientific uncertainties that surround the link between testosterone concentrations and sexual difficulties. Procter & Gamble has also agreed it will work with the FDA and try to provide additional safety data before the launch of the drug in the market.


'"/>




Related medicine news :

1. Testosterone Replacement Therapy Safe If Monitored Appropriately
2. Low Testosterone Levels the Cause Of Depression In Men
3. The Use Of Testosterone Replacement Therapy Questioned
4. Depression In Men Could Be To Low Testosterone Levels
5. Testosterone Patches Found To Increase Sexual Desire In Menopausal Women
6. Testosterone Therapy can improve sexual function in postmenopausal women
7. Fatherhood Found To Tame Men by Reducing Testosterone Levels
8. Testosterone levels could serve as a marker for determining risk of SIDS
9. Males Lifespan Shortened By Elevated Levels Of Testosterone
10. Study Indicates An Increased Risk Of Breast Cancer In Women Undertaking Estrogen and Testosterone Therapy
11. Low Testosterone Linked With Early Death
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/17/2019)... ... ... Whole Foods Market, along with Austin leaders, has joined forces with Blue Zones ... assessment by the Blue Zones team of the Austin Metro area and population that ... work, grow up, and grow old. , Blue Zones is based on research and ...
(Date:10/15/2019)... , ... October 15, 2019 , ... ... FDA’s Most Recent IFU Guidance , **An FDAnews Webinar**, Tuesday, October 29, 2019, ... for Use (IFU) guidance have on new drug applications and biologics license applications? ...
(Date:10/15/2019)... (PRWEB) , ... October 15, 2019 , ... Nashville Fertility ... be the latest fertility doctor to join the practice. In addition to treating general ... syndrome (PCOS). , The team at NFC looks forward to Dr. Van Heertum joining ...
(Date:10/11/2019)... ... ... A Topping Out event was hosted today at the construction site of the ... The event celebrated reaching the final height of the structure set to open in ... kind in Texas, STA’s facility will be home to an organ recovery center including ...
(Date:10/10/2019)... ... 10, 2019 , ... Caring.com, a leading senior care referral service with Family ... for Seniors to Live. All 50 states and 302 cities in the U.S. were ... development. , According to the U.S. Census Bureau , almost 20 million ...
Breaking Medicine News(10 mins):
(Date:10/19/2019)... ... October 18, 2019 , ... Beginnings Treatment Centers, a ... as the official sponsor of the Alcohol and Other Drug Awareness Week ... students to make informed decisions around alcohol and other drugs through individual education and ...
(Date:10/17/2019)... (PRWEB) , ... October 17, 2019 , ... ... patients with neuroblastoma, a deadly pediatric nerve cancer, who would otherwise have no ... , Neuroblastoma is one of the most common and aggressive pediatric nervous system ...
(Date:10/15/2019)... ... October 14, 2019 , ... ... linearity and calibration verification kit, for Roche cobas® analyzers, Order No. 507ro. ... B (Apo-B). Each VALIDATE® LP2 kit, liquid, ready-to-use, and prepared using ...
Breaking Medicine Technology: